MangoRx TRT Review

Partly. MangoRx's oral Prime is built on Kyzatrex, an FDA-approved oral testosterone, so that line is FDA-approved. But its Mojo enclomiphene formula and its GLP-1 weight-loss line are compounded, which means they are NOT FDA-approved and are not reviewed for safety, efficacy, or quality before marketing, the same caveat that applies to compounded enclomiphene generally. The FDA-vs-compounded status of the $99 injectable is not clearly disclosed on the funnel. See our enclomiphene guide and the FDA's compounding page for the distinction.

MangoRx scores 7.0/10 on our weighted methodology and carries a Transparency Grade of C (A-F scale for what it discloses before intake). Flags we track: TRT is one line on a broad men's-health platform (GLP-1, ED, hair), not a specialty [Verified July 2026] Independent review base is tiny (~12) and platform-wide, not TRT-specific [Reported] Funnel is JS-blocked to crawlers; the $99 price is verified via the company's own release, not a direct read [Verified July 2026] Some products (Mojo enclomiphene, GLP-1) are compounded and therefore NOT FDA-approved; status not clearly disclosed [Reported] No clinicians named; no published cancellation policy surfaced [Reported] Facts last verified July 8, 2026.

Entry pricing starts around $99/mo. Consult fee: Included in the $99/mo all-inclusive program [Reported]. Injectable TRT at $99/mo x 12 = $1,188, all-inclusive (doctor visits, consultations, lab work and analysis, and medication included, per the company's launch release) [Reported, pending a manual browser price verification]. The labs-included structure makes its year-one total lower than PeterMD's ($1,317, labs billed separately), though both headline at $99/mo.

No. MangoRx is cash-pay, and entry pricing starts around $99/mo. It does not bill insurance for treatment.

MangoRx's stated policy: Subscription; specific cancellation terms not surfaced [Reported].

As of our last check: Injectable testosterone ($99/mo all-inclusive program) [Reported via company release]; Oral testosterone (Prime, built on the FDA-approved oral testosterone Kyzatrex) [Reported]; Enclomiphene (Mojo: enclomiphene citrate + DHEA + pregnenolone oral dissolvable tablet, compounded, not FDA-approved) [Reported]; Adjunct (non-TRT) lines: GLP-1 weight loss (compounded semaglutide/tirzepatide), ED, hair loss.

42 states [Reported].

Lab work and analysis are included in the $99/mo program; a baseline panel is part of onboarding, though 'required before prescribing' is not explicitly stated ('where necessary') [Reported].

Licensed healthcare providers (physicians); prescriptions are reviewed after a medical evaluation and lab testing, with no clinicians named [Reported].

MangoRx earns a C on our A-F transparency scale, which grades what a provider discloses BEFORE intake: pricing, named clinicians with credentials, a published cancellation policy, corporate disclosure, and third-party review accessibility. Key evidence: Publishes a real, flat all-inclusive TRT price ($99/mo covering visits, labs, and medication), computable to a clean first-year total, a pass on the axis this site weights most [Reported via company release; product page JS-blocked] Corporate disclosure is a genuine strength: a public company (Mangoceuticals, Inc., NASDAQ: MGRX, Dallas, TX), the entity transparency PeterMD and Maximus lack [Verified July 2026] Independent reviews are reachable (a Trustpilot page exists), but the base is tiny (~12) and platform-wide across TRT, GLP-1, ED, and hair, so we relevance-gate it: no rating credit, no penalty [Reported] Fails two grade criteria: no named clinicians (only 'licensed providers') and no published cancellation policy [Reported] Funnel is JS-rendered/blocked to verification crawlers, so its prices are verified via the company's own release plus third-party cross-check, not a direct funnel read [Verified July 2026, block observed]